Back to top

Buy Rating Affirmed: LeMaitre Vascular’s Growth and Profitability Outlook

Stifel Nicolaus analyst Rick Wise upgraded the rating on Lemaitre Vascular (LMAT – Research Report) to a Buy today, setting a price target of $75.0...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

LeMaitre Vascular, Inc. (LMAT)